Guest post: Catriona Hammer on the CIPA Congress

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

Guest post: Catriona Hammer on the CIPA Congress

The CIPA President outlines the agenda for this week’s annual Congress

We are very excited about our annual Congress this week and are delighted that our IP Minister, Baroness Neville-Rolfe, will be attending to give the opening keynote address. Her business background should give her plenty to say on the topic of IP.

She has already led a highly successful delegation to China in which CIPA was pleased to be represented by Gwilym Roberts.

The Congress theme is “The Lifecycle of Intellectual Property: Intellectual property from cradle to grave”. We look forward to hearing from a full programme of distinguished speakers taking us all the way through from recognising inventions to licensing and litigation.



There will be a keynote speech from Heli Pihlajamaa of the EPO after lunch on the opening day.

In addition, we expect a provocative lunchtime debate on the second day when Dr Mohga Kamal-Yanni, Senior Health and HIV Policy Advisor for Oxfam GB, will speak on the effect that the charity believes “Big Pharma” companies are having on public health in the developing world and John Pender from Glaxo Smithkline will reply for the industry.

For those attending the President’s Dinner, there will be the Rt Hon The Lord Justice Vos as guest speaker – plus a few surprises in store.

There is certainly a lot happening in the world of IP and CIPA is actively engaged in a diverse range of issues such as: the European Trade Mark Directive and Regulations; the proposed Trade Secrets Directive and, of course, the ongoing saga of the Unitary Patent and Unified Patent Court. All of these topics feature on the agenda for Congress and, of course, we expect to get many contributions and questions from the audience.

more from across site and SHARED ros bottom lb

More from across our site

Amita Haylock discusses building an integrated Asia practice as clients increasingly demand that firms combine IP, technology and data expertise
François Pochart, Grégoire Desrousseaux and Lionel Martin, long-standing figures in the firm’s patent litigation team, are set to help launch a Paris-based litigation offering
The Unitary Patent has passed 100,000 registrations, but new data raises the question of whether 30% uptake is a ceiling or a staging post for further growth, say Michael Nielsen and Darren Smyth of EIP and Andrew Samm at Patently
The new generation of in-house IP leaders want commercial judgment, accessibility and flexibility, with AI raising expectations around both fees and delivery
The firm launched a San Diego office earlier this month, but California investment and expansion is far from complete
The industry’s response to AI requires an unfamiliar ingredient as firms battle to shape their futures
The firm is looking beyond replacing recently departed talent, betting instead on senior leaders to strengthen and expand its patent litigation platform
Olga Partington, director in Sterne Kessler’s biotechnology and chemical practice group, shares why a patent's vulnerability peaks when it is young, rather than when it is most valuable, under the PTAB's new framework
IP experts gathered in San Francisco last week to discuss the changing global SEP landscape and new licensing models for AI infrastructure
SKW Schwarz partner Daniel Kendziur explains how new green claims rules are changing his workload and bringing him into direct contact with marketing, PR and government affairs teams
Gift this article